DSGN · Company research

Design Therapeutics, Inc. Common Stock (DSGN): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

14records availableHealthcare

Stock News & Events data

Database-backed records only

14 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Liquidity Mapping Around (DSGN) Price Events - Stock Traders DailyLiquidity Mapping Around (DSGN) Price Events Stock Traders DailyView source ↗Stock Traders DailyOct 7, 2026neutral00.6
DSGN Q2 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline at Clinical-Stage Biotech - Forward Guidance Trends - dars.gov.etDSGN Q2 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline at Clinical-Stage Biotech - Forward Guidance Trends dars.gov.etView source ↗dars.gov.etSep 29, 2026neutral00.6
Liquidity Mapping Around (DSGN) Price Events - Stock Traders DailyLiquidity Mapping Around (DSGN) Price Events Stock Traders DailyView source ↗Stock Traders DailySep 7, 2026neutral00.6
A biotech company's conference chat will be webcast live Sept. 9. - Stock TitanA biotech company's conference chat will be webcast live Sept. 9. Stock TitanView source ↗Stock TitanSep 2, 2026neutral00.6
Design Therapeutics (DSGN) Holds Above $15 as Shares Slip 0.92% - ETF NAV Deviation - dars.gov.etDesign Therapeutics (DSGN) Holds Above $15 as Shares Slip 0.92% - ETF NAV Deviation dars.gov.etView source ↗dars.gov.etAug 30, 2026neutral00.6
Responsive Playbooks and the DSGN Inflection - Stock Traders DailyResponsive Playbooks and the DSGN Inflection Stock Traders DailyView source ↗Stock Traders DailyAug 27, 2026neutral00.6
A Deeper Dive Into Design Therapeutics (NASDAQ:DSGN) - Seeking AlphaA Deeper Dive Into Design Therapeutics (NASDAQ:DSGN) Seeking AlphaView source ↗Seeking AlphaJul 27, 2026neutral00.6
We're Hopeful That Design Therapeutics (NASDAQ:DSGN) Will Use Its Cash Wisely - Simply Wall StreetWe're Hopeful That Design Therapeutics (NASDAQ:DSGN) Will Use Its Cash Wisely Simply Wall StreetView source ↗Simply Wall StreetJun 27, 2026neutral00.6
Design Therapeutics: FA Early Data And FDA Discussions Are Promising Catalysts - Seeking AlphaDesign Therapeutics: FA Early Data And FDA Discussions Are Promising Catalysts Seeking AlphaView source ↗Seeking AlphaJun 24, 2026neutral00.6
Design Therapeutics Stock Wobbles After Rare Genetic Disease Data - Design Therapeutics (NASDAQ:DSGN) - BenzingaDesign Therapeutics Stock Wobbles After Rare Genetic Disease Data - Design Therapeutics (NASDAQ:DSGN) BenzingaView source ↗BenzingaMay 18, 2026neutral00.6
This Biotech Leader Ran Up As Much As 18% — And Then Lost It All - Investor's Business DailyThis Biotech Leader Ran Up As Much As 18% — And Then Lost It All Investor's Business DailyView source ↗Investor's Business DailyMay 18, 2026neutral00.6
Design Therapeutics, Inc. Stock 12‑Month Price Target Raised to $20, Implies 39% Upside - TradingViewDesign Therapeutics, Inc. Stock 12‑Month Price Target Raised to $20, Implies 39% Upside TradingViewView source ↗TradingViewMay 18, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNJan 15, 2024neutral00.6
Design Therapeutics, Inc. (DSGN) Stock Price, News, Quote & History - Yahoo! Finance CanadaDesign Therapeutics, Inc. (DSGN) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaMar 26, 2021neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.